Annual ROA
-19.13%
-1.51%-8.57%
31 December 2023
Summary:
Lineage Cell Therapeutics annual return on assets is currently -19.13%, with the most recent change of -1.51% (-8.57%) on 31 December 2023. During the last 3 years, it has fallen by -1.44% (-8.14%). LCTX annual ROA is now -167.60% below its all-time high of 28.30%, reached on 31 December 2016.LCTX ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-19.52%
+3.29%+14.42%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly return on assets is currently -19.52%, with the most recent change of +3.29% (+14.42%) on 30 September 2024. Over the past year, it has increased by +0.16% (+0.81%). LCTX quarterly ROA is now -126.55% below its all-time high of 73.52%, reached on 31 March 2017.LCTX Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.6% | +0.8% |
| 3 y3 years | -8.1% | -97.0% |
| 5 y5 years | +42.8% | +44.2% |
LCTX ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -8.6% | +37.2% | -97.0% | +44.5% |
| 5 y | 5 years | -85.5% | +42.8% | -131.8% | +53.2% |
| alltime | all time | -167.6% | +96.9% | -126.5% | +96.5% |
Lineage Cell Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -19.52%(-14.4%) |
| June 2024 | - | -22.81%(+4.3%) |
| Mar 2024 | - | -21.88%(+13.2%) |
| Dec 2023 | -19.13%(+8.6%) | -19.33%(-1.8%) |
| Sept 2023 | - | -19.68%(+10.0%) |
| June 2023 | - | -17.89%(-1.5%) |
| Mar 2023 | - | -18.16%(-1.9%) |
| Dec 2022 | -17.62%(-42.2%) | -18.51%(-45.7%) |
| Sept 2022 | - | -34.09%(-3.0%) |
| June 2022 | - | -35.14%(+2.9%) |
| Mar 2022 | - | -34.15%(+7.4%) |
| Dec 2021 | -30.46%(+72.2%) | -31.80%(+220.9%) |
| Sept 2021 | - | -9.91%(-2.7%) |
| June 2021 | - | -10.18%(-15.1%) |
| Mar 2021 | - | -11.99%(-34.1%) |
| Dec 2020 | -17.69%(+71.6%) | -18.19%(-20.6%) |
| Sept 2020 | - | -22.92%(-18.1%) |
| June 2020 | - | -28.00%(-32.8%) |
| Mar 2020 | - | -41.68%(+395.0%) |
| Dec 2019 | -10.31%(-69.2%) | -8.42%(-75.9%) |
| Sept 2019 | - | -34.97%(-263.4%) |
| June 2019 | - | 21.40%(-48.5%) |
| Mar 2019 | - | 41.56%(-221.7%) |
| Dec 2018 | -33.46%(+164.5%) | -34.14%(-25.7%) |
| Sept 2018 | - | -45.96%(-40.5%) |
| June 2018 | - | -77.29%(+5.2%) |
| Mar 2018 | - | -73.45%(+588.4%) |
| Dec 2017 | -12.65%(-144.7%) | -10.67%(-141.5%) |
| Sept 2017 | - | 25.74%(-36.0%) |
| June 2017 | - | 40.20%(-45.3%) |
| Mar 2017 | - | 73.52%(+149.4%) |
| Dec 2016 | 28.30%(-151.1%) | 29.48%(+17.7%) |
| Sept 2016 | - | 25.04%(-211.2%) |
| June 2016 | - | -22.51%(-66.5%) |
| Mar 2016 | - | -67.16%(+13.3%) |
| Dec 2015 | -55.43%(+0.9%) | -59.27%(-4.0%) |
| Sept 2015 | - | -61.77%(+10.4%) |
| June 2015 | - | -55.96%(-5.9%) |
| Mar 2015 | - | -59.44%(+1.8%) |
| Dec 2014 | -54.91%(-45.3%) | -58.41%(-31.1%) |
| Sept 2014 | - | -84.83%(-7.4%) |
| June 2014 | - | -91.59%(-8.2%) |
| Mar 2014 | - | -99.82%(-12.0%) |
| Dec 2013 | -100.33%(+76.9%) | -113.38%(+26.2%) |
| Sept 2013 | - | -89.84%(+20.5%) |
| June 2013 | - | -74.53%(+8.1%) |
| Mar 2013 | - | -68.95%(+19.6%) |
| Dec 2012 | -56.70%(+70.1%) | -57.65%(+15.0%) |
| Sept 2012 | - | -50.13%(+16.8%) |
| June 2012 | - | -42.92%(+15.1%) |
| Mar 2012 | - | -37.29%(+16.0%) |
| Dec 2011 | -33.33%(-0.6%) | -32.15%(+14.6%) |
| Sept 2011 | - | -28.05%(-12.2%) |
| June 2011 | - | -31.96%(-4.4%) |
| Mar 2011 | - | -33.44%(-7.4%) |
| Dec 2010 | -33.53%(-52.8%) | -36.12%(+17.8%) |
| Sept 2010 | - | -30.67%(-18.9%) |
| June 2010 | - | -37.84%(-34.0%) |
| Mar 2010 | - | -57.29%(-30.5%) |
| Dec 2009 | -71.11%(-88.6%) | -82.41%(-61.9%) |
| Sept 2009 | - | -216.12%(-22.1%) |
| June 2009 | - | -277.41%(-43.3%) |
| Mar 2009 | - | -489.30%(-11.8%) |
| Dec 2008 | -624.65% | -554.79%(+6.2%) |
| Sept 2008 | - | -522.32%(+0.1%) |
| June 2008 | - | -521.79%(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | -497.90%(+0.7%) |
| Dec 2007 | -348.40%(+143.8%) | -494.26%(+40.8%) |
| Sept 2007 | - | -351.00%(+39.0%) |
| June 2007 | - | -252.50%(+24.0%) |
| Mar 2007 | - | -203.70%(+38.8%) |
| Dec 2006 | -142.92%(+19.9%) | -146.71%(-6.8%) |
| Sept 2006 | - | -157.49%(-5.4%) |
| June 2006 | - | -166.47%(+6.7%) |
| Mar 2006 | - | -156.00%(-15.6%) |
| Dec 2005 | -119.20%(-49.9%) | -184.82%(-8.3%) |
| Sept 2005 | - | -201.61%(+27.9%) |
| June 2005 | - | -157.67%(+22.6%) |
| Mar 2005 | - | -128.62%(-27.7%) |
| Dec 2004 | -237.96%(+75.4%) | -177.92%(-4.1%) |
| Sept 2004 | - | -185.54%(+21.8%) |
| June 2004 | - | -152.31%(-20.4%) |
| Mar 2004 | - | -191.41%(+33.9%) |
| Dec 2003 | -135.70%(-18.0%) | -142.91%(+4.0%) |
| Sept 2003 | - | -137.44%(-38.4%) |
| June 2003 | - | -222.97%(+6.1%) |
| Mar 2003 | - | -210.09%(+9.3%) |
| Dec 2002 | -165.53%(-18.1%) | -192.27%(+18.4%) |
| Sept 2002 | - | -162.35%(-24.8%) |
| June 2002 | - | -215.88%(-8.0%) |
| Mar 2002 | - | -234.61%(-1.5%) |
| Dec 2001 | -202.21%(+51.0%) | -238.11%(-6.2%) |
| Sept 2001 | - | -253.94%(-2.4%) |
| June 2001 | - | -260.27%(+34.1%) |
| Mar 2001 | - | -194.04%(+30.3%) |
| Dec 2000 | -133.90%(+3.7%) | -148.97%(+21.6%) |
| Sept 2000 | - | -122.52%(+6.5%) |
| June 2000 | - | -115.07%(+29.9%) |
| Mar 2000 | - | -88.58%(+8.5%) |
| Dec 1999 | -129.12%(+127.8%) | -81.63%(+3.9%) |
| Sept 1999 | - | -78.55%(+46.5%) |
| June 1999 | - | -53.63%(-8.1%) |
| Mar 1999 | - | -58.33%(+0.4%) |
| Dec 1998 | -56.68%(+4.5%) | - |
| Sept 1998 | - | -58.10%(+19.5%) |
| June 1998 | - | -48.63%(-5.4%) |
| June 1998 | -54.26%(+2.2%) | - |
| Mar 1998 | - | -51.39%(+8.4%) |
| Dec 1997 | - | -47.40%(-18.1%) |
| Sept 1997 | - | -57.89%(-8.2%) |
| June 1997 | -53.10%(-12.4%) | -63.03%(-2.3%) |
| Mar 1997 | - | -64.52%(-35.5%) |
| Dec 1996 | - | -100.00%(+18.0%) |
| Sept 1996 | - | -84.71%(+35.5%) |
| June 1996 | -60.61%(+19.9%) | -62.50%(+1.3%) |
| Mar 1996 | - | -61.68%(+7.9%) |
| Dec 1995 | - | -57.14%(+8.6%) |
| Sept 1995 | - | -52.63%(+4.4%) |
| June 1995 | -50.53%(+58.4%) | -50.42%(+27.7%) |
| Mar 1995 | - | -39.47%(+11.0%) |
| Dec 1994 | - | -35.57%(+7.1%) |
| Sept 1994 | - | -33.20%(+4.8%) |
| June 1994 | -31.91%(+10.3%) | -31.67%(-2.1%) |
| Mar 1994 | - | -32.34%(-4.1%) |
| Dec 1993 | - | -33.71%(+19.5%) |
| Sept 1993 | - | -28.21%(+6.7%) |
| June 1993 | -28.92%(+98.4%) | -26.44%(+19.0%) |
| Mar 1993 | - | -22.22%(+3.3%) |
| Dec 1992 | - | -21.51%(+48.5%) |
| Sept 1992 | - | -14.48%(+81.0%) |
| June 1992 | -14.58% | -8.00%(+107.8%) |
| Mar 1992 | - | -3.85% |
FAQ
- What is Lineage Cell Therapeutics annual return on assets?
- What is the all time high annual ROA for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual ROA year-on-year change?
- What is Lineage Cell Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly ROA year-on-year change?
What is Lineage Cell Therapeutics annual return on assets?
The current annual ROA of LCTX is -19.13%
What is the all time high annual ROA for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual return on assets is 28.30%
What is Lineage Cell Therapeutics annual ROA year-on-year change?
Over the past year, LCTX annual return on assets has changed by -1.51% (-8.57%)
What is Lineage Cell Therapeutics quarterly return on assets?
The current quarterly ROA of LCTX is -19.52%
What is the all time high quarterly ROA for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly return on assets is 73.52%
What is Lineage Cell Therapeutics quarterly ROA year-on-year change?
Over the past year, LCTX quarterly return on assets has changed by +0.16% (+0.81%)